Analysis of Human Herpesvirus Type 8 Infection in AIDS-Related and AIDS-Unrelated Primary Central Nervous System Lymphoma

Human herpesvirus type 8 (HHV-8) has been proposed as a pathogenetic factor for immunosuppression-associated primary central nervous system lymphoma (PCNSL). To verify this hypothesis, HHV-8 infection was investigated in 31 persons with PCNSL (16 AIDS-related, 15 AIDS-unrelated) and in 30 persons wi...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 175; no. 5; pp. 1193 - 1197
Main Authors Gaidano, Gianluca, Capello, Daniela, Pastore, Cristina, Antinori, Andrea, Gloghini, Annunziata, Carbone, Antonino, Larocca, Luigi Maria, Saglio, Giuseppe
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.05.1997
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human herpesvirus type 8 (HHV-8) has been proposed as a pathogenetic factor for immunosuppression-associated primary central nervous system lymphoma (PCNSL). To verify this hypothesis, HHV-8 infection was investigated in 31 persons with PCNSL (16 AIDS-related, 15 AIDS-unrelated) and in 30 persons with systemic B cell non-Hodgkin's lymphomas (B-NHL; 15 AIDS-related, 15 AIDS-unrelated). All subjects with PCNSL scored negative by single-step polymerase chain reaction (PCR), suggesting a tumor virus load of < 100 viral copies/200,000 human haploid genome equivalents (HHGE). By applying Poisson assumptions to nested PCR, 16 of 31 persons with PCNSL were devoid of HHV-8 sequences: 1 subject with AIDS and PCNSL had 1–100 viral copies/200,000 HHGE, and 14 with PCNSL had <1 viral copy/200,000 HHGE. Similarly, 10 of 30 persons with systemic B-NHL were devoid of HHV-8 sequences; 20 had <1 viral copy/200,000 HHGE. The extremely low levels of infection rule out a role of HHV-8 in PCNSL pathogenesis and are consistent with HHV-8 infection of bystander cells contaminating the tumor clone.
Bibliography:istex:1A3F1E0DAA86321EF3BFCA51176942F86F13FEF5
Reprints or correspondence: Dr. Gianluca Gaidano, Division of Internal Medicine, Department of Medical Sciences, University of Turin at Navara, Via Solaroli 17, 28100 Novara, Italy.
Financial support: IX Progetto AIDS, Istituto Superiore di Sanitá, Rome (grants 9404-33, 9404-04, and 9404-26), Fondazione Piera, Pietro e Giovanni Ferrero, Alba, Italy (grant), and Associazione Italiana per la Ricerca contro il Cancro, Milan (fellowships to C.P.).
ark:/67375/HXZ-J2ZB7Q6K-G
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1086/593456